Pharmaceutical combination of Bcr-Abl and RAF inhibitors

Details for Australian Patent Application No. 2006218020 (hide)

Owner Novartis AG

Inventors Manley, Paul W.

Agent Davies Collison Cave

Pub. Number AU-A-2006218020

PCT Pub. Number WO2006/089781

Priority 60/656,340 25.02.05 US

Filing date 24 February 2006

Wipo publication date 31 August 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/089781 Priority application(s): WO2006/089781

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218023-Toothbrush

2006218012-Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission